These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8957501)

  • 1. Notification of a family history of breast cancer: issues of privacy and confidentiality.
    Winter PR; Wiesner GL; Finnegan J; Bartels D; LeRoy B; Chen PL; Sellers TA
    Am J Med Genet; 1996 Dec; 66(1):1-6. PubMed ID: 8957501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of potential sources of bias in a genetic epidemiologic study of breast cancer.
    Seybolt LM; Vachon C; Potter K; Zheng W; Kushi LH; McGovern PG; Sellers TA
    Genet Epidemiol; 1997; 14(1):85-95. PubMed ID: 9055064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
    Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
    Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk assessment: quality and impact of the family history interview.
    Murff HJ; Byrne D; Syngal S
    Am J Prev Med; 2004 Oct; 27(3):239-45. PubMed ID: 15450637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
    Dickens BM; Pei N; Taylor KM
    CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
    Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
    Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families.
    Sellers TA; King RA; Cerhan JR; Chen PL; Grabrick DM; Kushi LH; Oetting WS; Vierkant RA; Vachon CM; Couch FJ; Therneau TM; Olson JE; Pankratz VS; Hartmann LC; Anderson VE
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1051-7. PubMed ID: 10613336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based screening for hereditary breast cancer in a region of North-Central Italy.
    Casadei S; Falcini F; Naldoni C; Amadori D; Calistri D
    Int J Mol Med; 2002 Sep; 10(3):299-305. PubMed ID: 12165804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium.
    Rimer BK; Schildkraut JM; Lerman C; Lin TH; Audrain J
    Cancer; 1996 Jun; 77(11):2348-55. PubMed ID: 8635106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of first-degree relatives of women with breast cancer: a feasibility study.
    Hurt GJ; McQuellon RP; Michielutte R; Conrad DM; Carter S; Anderson H
    Oncol Nurs Forum; 2001 Aug; 28(7):1097-104. PubMed ID: 11517843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women.
    Olson JE; Sellers TA; Anderson KE; Folsom AR
    Cancer; 1999 Jun; 85(11):2444-9. PubMed ID: 10357416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
    Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
    Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials.
    Marcus AC; Ahnen D; Cutter G; Calonge N; Russell S; Sedlacek SM; Wood M; Manchester D; Fox L; McCaskill-Stevens W; Fairclough D; Hines S; Wenzel L; Osborn K
    Prev Med; 1999 Mar; 28(3):229-42. PubMed ID: 10072740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.